近年来,随着对乳腺癌发病机制认识的不断深入以及辅助治疗的进步,乳腺癌根治性手术后Ⅰ期假体乳房再造,已得到发达国家认同。临床实践证实,乳腺癌根治性术后化疗治疗和内分泌治疗的生存率逐年增高,使得乳腺癌根治性手术后Ⅰ期乳房再造适应症也有扩大的趋势,国内已有不少学者对? In recent years, with the deepening understanding of the pathogenesis of breast cancer and the progress of adjuvant therapy, stage I breast reconstruction after breast cancer radical surgery has been recognized by developed countries. Clinical practice confirmed that the radical postoperative chemotherapy and endocrine therapy of breast cancer survival rate increased year by year, making breast cancer radical surgery Ⅰ breast reconstruction indications also have the tendency to expand, many scholars have?